A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women

NCT06393673 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms

Interventions

DRUG: HS-10384 tablet Dose 1
DRUG: HS-10384 tablet Dose 2
DRUG: HS-10384-matched placebo tablets

Sponsor

Hansoh BioMedical R&D Company